Publicaciones en las que colabora con MARIO ENCINAS MARTIN (30)

2024

  1. Sprouty1 is a broad mediator of cellular senescence

    Cell Death and Disease, Vol. 15, Núm. 4

2023

  1. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science, Vol. 10, Núm. 32

  2. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling

    Biomedicine and Pharmacotherapy, Vol. 168

  3. Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis

    Cancer Communications

2022

  1. A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 10

  2. Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Endometrial pten deficiency leads to smad2/3 nuclear translocation

    Cancers, Vol. 13, Núm. 19

2019

  1. Barley β-glucan accelerates wound healing by favoring migration versus proliferation of human dermal fibroblasts

    Carbohydrate Polymers, Vol. 210, pp. 389-398

  2. Sprouty1 controls genitourinary development via its N-terminal tyrosine

    Journal of the American Society of Nephrology, Vol. 30, Núm. 8, pp. 1398-1411

2017

  1. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium

    Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458

  2. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy, Vol. 13, Núm. 3, pp. 608-624

  3. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164

2015

  1. Impaired Vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: Implications for atherosclerosis development

    PLoS ONE, Vol. 10, Núm. 8

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

  2. Nuclear factor-B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner

    Laboratory Investigation, Vol. 91, Núm. 6, pp. 859-871

  3. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma

    Human Pathology, Vol. 42, Núm. 2, pp. 185-193

  4. The canonical nuclear factor-κB pathway regulates cell survival in a developmental model of spinal cord motoneurons

    Journal of Neuroscience, Vol. 31, Núm. 17, pp. 6493-6503

2009

  1. 1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter

    Atherosclerosis, Vol. 204, Núm. 1, pp. 85-89

  2. Loss of Sprouty1 rescues renal agenesis caused by ret mutation

    Journal of the American Society of Nephrology, Vol. 20, Núm. 2, pp. 255-259

2008

  1. Analysis of Ret knockin mice reveals a critical role for IKKs, but not PI 3-K, in neurotrophic factor-induced survival of sympathetic neurons

    Cell Death and Differentiation, Vol. 15, Núm. 9, pp. 1510-1521